CE Credit: 1 CM
The session will enhance understanding as well as clarify terminology and nomenclature of current diagnostic approach and management strategies used by cardiovascular specialists, and also provide an update on current and emerging technologies used by cardiologists in acute coronary syndromes as well as acute and chronic heart failure.
While cardiovascular disease remains the primary cause of morbidity and mortality in the United States, remarkable progress has been made in this specialty over the last two decades to decrease mortality rates from myocardial infarction, sudden cardiac death, and congestive heart failure.
Even now, as our Congress and our Citizenry engage in heated debate about the delivery of health care, remarkable technological developments continue to emerge with profound beneficial impact on the quality of life for our patients and their loved ones.
This session will focus on emerging strategies such as evolving coronary stent technologies, life-vest ICDs, biventricular ICDs for refractory heart failure, percutaneous circulatory support devices for high-risk coronary interventions, and mechanical ambulatory circulatory support devices in chronic heart failure (LVADs). It will also touch on research protocols related to stem-cell infusion as a treatment to regenerate cardiac tissue in acute MI, bioprosthetic valves, and emerging developments in clinical pharmacology.
Speaker Bio
John Hays, MD, FACC, grew up in Austin, Texas. He has a BA with high honors from UT Houston Medical School and was chief resident at Baylor College of Medicine in 1989. Dr. Hays was an instructor at BenTaub General Hospital from 1992-1993 and served as an aeromedical services flight physician from 1989 – 1992. He is a published author and was a managing partner of Austin Cardiovascular Associates in 1997, 1998, and 2005.